Evidence map›Paper›PMID 28499703›Full record

ArticleThe American journal of pathology2017

miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.

Lizandra Jimenez, Jihyeon Lim, Berta Burd, Thomas M Harris, Thomas J Ow, Nicole Kawachi, Thomas J Belbin, Ruth Angeletti, Michael B Prystowsky, Geoffrey Childs and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Article
  7. Preeclampsia-Associated lncRNAMolecular therapy. Nucleic acids · 2020
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Lizandra JimenezDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York; Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York.
Jihyeon LimDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York; Laboratory for Macromolecular Analysis and Proteomics, Albert Einstein College of Medicine, Bronx, New York.
Berta BurdLaboratory for Macromolecular Analysis and Proteomics, Albert Einstein College of Medicine, Bronx, New York.
Thomas M HarrisDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York.
Thomas J OwDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York.
Nicole KawachiDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York.
Thomas J BelbinDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York.
Ruth AngelettiLaboratory for Macromolecular Analysis and Proteomics, Albert Einstein College of Medicine, Bronx, New York.
Michael B PrystowskyDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York.
Geoffrey ChildsDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York.
Jeffrey E SegallDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York; Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York. Electronic address: jeffrey.segall@einstein.yu.edu.
Albert Einstein College of Medicine · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
Tumor Progression and MetastasisP01CA100324 · NCI · YESHIVA UNIVERSITY · PI CONDEELIS, JOHN S · 2003 to 2018
$30.0M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Paul Calabresis Career Development Award For Clinical Oncology K12CA132783 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI PEREZ-SOLER, ROMAN, VERMA, AMIT K. · 2009 to 2019
$8.2M
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASISR01CA077522 · NCI · YESHIVA UNIVERSITY · PI SEGALL, JEFFREY E · 2000 to 2011
$3.0M
Role of miRNA-375 in Invasive Phenotype of Head and Neck Squamous Cell CarcinomaF31CA168337 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JIMENEZ, LIZANDRA · 2012 to 2014
$195k
NCATS NIH HHS UL1 TR001073NCI NIH HHS F31 CA168337NCI NIH HHS K12 CA132783NCI NIH HHS P01 CA100324NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA077522
6 · The paper itself

Abstract

Invasion is a hallmark of advanced head and neck squamous cell carcinoma (HNSCC). We previously determined that low relative miR-375 expression was associated with poor patient prognosis. HNSCC cells with increased miR-375 expression have lower invasive properties and impaired invadopodium activity. Using stable isotope labeling with amino acids in cell culture and reverse-phase liquid chromatography mass spectrometry, we assessed the impact of miR-375 expression on protein levels in UM-SCC-1 cells. Increased miR-375 expression was associated with down-regulation of proteins involved in cellular assembly and organization, death and survival, and movement. Two invasion-associated proteins, vimentin and L-plastin, were strongly down-regulated by miR-375. Luciferase reporter assays demonstrated that high miR-375 expression reduced vimentin promoter activity, suggesting that vimentin is an indirect target of miR-375. Runt-related transcription factor 1 (RUNX1) is a potential miR-375 direct target, and its knockdown reduced vimentin and L-plastin expression. Data in The Cancer Genome Atlas HNSCC database showed a significant inverse correlation between miR-375 expression and RUNX1, vimentin, and L-plastin RNA expression. These clinical correlations validate our in vitro model findings and support a mechanism in which miR-375 suppresses RUNX1 levels, resulting in reduced vimentin and L-plastin expression. Furthermore, knockdown of RUNX1, L-plastin, and vimentin resulted in significant reductions in cell invasion in vitro, indicating the functional significance of miR-375 regulation of specific proteins involved in HNSCC invasion.

Indexed as

Carcinoma, Squamous CellCore Binding Factor Alpha 2 SubunitDown-RegulationGene Expression Regulation, NeoplasticGene Knockdown TechniquesHead and Neck NeoplasmsHumansMicrofilament ProteinsMicroRNAsModels, BiologicalNeoplasm InvasivenessNeoplasm ProteinsProteomicsSquamous Cell Carcinoma of Head and NeckVimentinCore Binding Factor Alpha 2 SubunitLCP1 protein, humanMicrofilament ProteinsMicroRNAsMIRN375 microRNA, humanNeoplasm ProteinsRUNX1 protein, humanVimentin

Identifiers

PMID28499703
PMCPMC5500828
OpenAlexW2613209216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.